Mark Janse

Mr. Mark Janse

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2023 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Open access
MJMark Janse
Mark Janse
LJLiselore M. Janssen
Liselore M. Janssen
BVBas H. M. van der Velden
Bas H. M. van der Velden
MMMaaike R. Moman
Maaike R. Moman
EBElian J. M. Wolters‐Van der Ben
Elian J. M. Wolters‐Van der Ben
Kenneth G. A. GilhuijsKenneth G. A. Gilhuijs
Kenneth G. A. Gilhuijs
Background: While several methods have been proposed for automated assessment of breast‐cancer response to neoadjuvant chemotherapy on breast MRI, limited information is available about their performance across multiple institutions.Purpose: To assess the value and robustness of deep learning‐derived volumes of locally advanced breast cancer (LABC) on MRI to infer the presence of residual disease after neoadjuvant chemotherapy.Study Type: Retrospective.Subjects: Training cohort: 102 consecutive female patients with LABC scheduled for neoadjuvant chemotherapy (NAC) from a single institution (age: 25–73 years). Independent testing cohort: 55 consecutive female patients with LABC from four institutions (age: 25–72 years).Field Strength/Sequence: Training cohort: single vendor 1.5 T or 3.0 T. Testing cohort: multivendor 3.0 T. Gradient echo dynamic contrast‐enhanced sequences.Assessment: A convolutional neural network (nnU‐Net) was trained to segment LABC. Based on resulting tumor volumes, an extremely randomized tree model was trained to assess residual cancer burden (RCB)‐0/I vs. RCB‐II/III. An independent model was developed using functional tumor volume (FTV). Models were tested on an independent testing cohort and response assessment performance and robustness across multiple institutions were assessed.Statistical Tests: The receiver operating characteristic (ROC) was used to calculate the area under the ROC curve (AUC). DeLong's method was used to compare AUCs. Correlations were calculated using Pearson's method. P values <0.05 were considered significant.Results: Automated segmentation resulted in a median (interquartile range [IQR]) Dice score of 0.87 (0.62–0.93), with similar volumetric measurements (R = 0.95, P < 0.05). Automated volumetric measurements were significantly correlated with FTV (R = 0.80). Tumor volume‐derived from deep learning of DCE‐MRI was associated with RCB, yielding an AUC of 0.76 to discriminate between RCB‐0/I and RCB‐II/III, performing similar to the FTV‐based model (AUC = 0.77, P = 0.66). Performance was comparable across institutions (IQR AUC: 0.71–0.84).Data Conclusion: Deep learning‐based segmentation estimates changes in tumor load on DCE‐MRI that are associated with RCB after NAC and is robust against variations between institutions.Evidence Level: 2.Technical Efficacy: Stage 4.

20 January 2024 in npj Breast Cancer
Verified
Journal Article
Open access
PDF file
LJL. M. Janssen
L. M. Janssen
MJMark Janse
Mark Janse
BVB. B. L. Penning de Vries
B. B. L. Penning de Vries
BVB. H. M. van der Velden
B. H. M. van der Velden
EBE. J. M. Wolters-Van der Ben
E. J. M. Wolters-Van der Ben
Kenneth G. A. GilhuijsKenneth G. A. Gilhuijs
Kenneth G. A. Gilhuijs
Accurate prediction of response to neoadjuvant chemotherapy (NAC) can help tailor treatment to individual patients’ needs. Little is known about the combination of liquid biopsies and computer extracted features from multiparametric magnetic resonance imaging (MRI) for the prediction of NAC response in breast cancer. Here, we report on a prospective study with the aim to explore the predictive potential of this combination in adjunct to standard clinical and pathological information before, during and after NAC. The study was performed in four Dutch hospitals. Patients without metastases treated with NAC underwent 3 T multiparametric MRI scans before, during and after NAC. Liquid biopsies were obtained before every chemotherapy cycle and before surgery. Prediction models were developed using penalized linear regression to forecast residual cancer burden after NAC and evaluated for pathologic complete response (pCR) using leave-one-out-cross-validation (LOOCV). Sixty-one patients were included. Twenty-three patients (38%) achieved pCR. Most prediction models yielded the highest estimated LOOCV area under the curve (AUC) at the post-treatment timepoint. A clinical-only model including tumor grade, nodal status and receptor subtype yielded an estimated LOOCV AUC for pCR of 0.76, which increased to 0.82 by incorporating post-treatment radiological MRI assessment (i.e., the “clinical-radiological” model). The estimated LOOCV AUC was 0.84 after incorporation of computer-extracted MRI features, and 0.85 when liquid biopsy information was added instead of the radiological MRI assessment. Adding liquid biopsy information to the clinical-radiological resulted in an estimated LOOCV AUC of 0.86. In conclusion, inclusion of liquid biopsy-derived markers in clinical-radiological prediction models may have potential to improve prediction of pCR after NAC in breast cancer.

24 March 2016
Verified
Conference Paper
Closed access
PDF file
MJMark Janse
Mark Janse
Fons van der SommenFons van der Sommen
Fons van der Sommen
SZSveta Zinger
Sveta Zinger
ESErik J. Schoon
Erik J. Schoon
PWPeter H. N. de With
Peter H. N. de With

13 October 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
GLGeke Litjens
Geke Litjens
JBJoris Broekmans
Joris Broekmans
Tim BoersTim Boers
Tim Boers
Marco CaballoMarco Caballo
Marco Caballo
MHMaud Hurk
Maud Hurk
JHJohn J . Hermans
John J . Hermans
The preoperative prediction of resectability pancreatic ductal adenocarcinoma (PDAC) is challenging. This retrospective single-center study examined tumor and vessel radiomics to predict the resectability of PDAC in chemo-naïve patients. The tumor and adjacent arteries and veins were segmented in the portal-venous phase of contrast-enhanced CT scans, and radiomic features were extracted. Features were selected via stability and collinearity testing, and least absolute shrinkage and selection operator application (LASSO). Three models, using tumor features, vessel features, and a combination of both, were trained with the training set (N = 86) to predict resectability. The results were validated with the test set (N = 15) and compared to the multidisciplinary team’s (MDT) performance. The vessel-features-only model performed best, with an AUC of 0.92 and sensitivity and specificity of 97% and 73%, respectively. Test set validation showed a sensitivity and specificity of 100% and 88%, respectively. The combined model was as good as the vessel model (AUC = 0.91), whereas the tumor model showed poor performance (AUC = 0.76). The MDT’s prediction reached a sensitivity and specificity of 97% and 84% for the training set and 88% and 100% for the test set, respectively. Our clinician-independent vessel-based radiomics model can aid in predicting resectability and shows performance comparable to that of the MDT. With these encouraging results, improved, automated, and generalizable models can be developed that reduce workload and can be applied in non-expert hospitals.

6 August 2025 in European Radiology
Verified
Journal Article
Open access
PDF file
MJMark Janse
Mark Janse
LJLiselore M. Janssen
Liselore M. Janssen
EBElian J. M. Wolters-Van der Ben
Elian J. M. Wolters-Van der Ben
MMMaaike R. Moman
Maaike R. Moman
MVMax A. Viergever
Max A. Viergever
Kenneth G. A. GilhuijsKenneth G. A. Gilhuijs
Kenneth G. A. Gilhuijs
Objectives: This study aimed to evaluate the potential additional value of deep radiomics for assessing residual cancer burden (RCB) in locally advanced breast cancer, after neoadjuvant chemotherapy (NAC) but before surgery, compared to standard predictors: tumor volume and subtype. Materials and methods: This retrospective study used a 105-patient single-institution training set and a 41-patient external test set from three institutions in the LIMA trial. DCE-MRI was performed before and after NAC, and RCB was determined post-surgery. Three networks (nnU-Net, Attention U-net and vector-quantized encoder-decoder) were trained for tumor segmentation. For each network, deep features were extracted from the bottleneck layer and used to train random forest regression models to predict RCB score. Models were compared to (1) a model trained on tumor volume and (2) a model combining tumor volume and subtype. The potential complementary performance of combining deep radiomics with a clinical-radiological model was assessed. From the predicted RCB score, three metrics were calculated: area under the curve (AUC) for categories RCB-0/RCB-I versus RCB-II/III, pathological complete response (pCR) versus non-pCR, and Spearman’s correlation. Results: Deep radiomics models had an AUC between 0.68–0.74 for pCR and 0.68–0.79 for RCB, while the volume-only model had an AUC of 0.74 and 0.70 for pCR and RCB, respectively. Spearman’s correlation varied from 0.45–0.51 (deep radiomics) to 0.53 (combined model). No statistical difference between models was observed. Conclusions: Segmentation network-derived deep radiomics contain similar information to tumor volume and subtype for inferring pCR and RCB after NAC, but do not complement standard clinical predictors in the LIMA trial. Key Points: Question It is unknown if and which deep radiomics approach is most suitable to extract relevant features to assess neoadjuvant chemotherapy response on breast MRI . Findings Radiomic features extracted from deep-learning networks yield similar results in predicting neoadjuvant chemotherapy response as tumor volume and subtype in the LIMA study. However, they do not provide complementary information . Clinical relevance For predicting response to neoadjuvant chemotherapy in breast cancer patients, tumor volume on MRI and subtype remain important predictors of treatment outcome; deep radiomics might be an alternative when determining tumor volume and/or subtype is not feasible . Graphical

26 October 2025 in Bioengineering
Verified
Journal Article
Open access
PDF file
MBMyrthe Buser
Myrthe Buser
Dominique Charlotte SimonsDominique Charlotte Simons
Dominique Charlotte Simons
MFMatthijs Fitski
Matthijs Fitski
MWMarc H.W.A. Wijnen
Marc H.W.A. Wijnen
ALAnnemieke S. Littooij
Annemieke S. Littooij
ASAlida FW van der Steeg
Alida FW van der Steeg
Surgery plays a key role in treating neuroblastoma. To assist surgical planning, anatomical 3D models derived from the segmentation of anatomical structures on MRI scans are often used. Automation using deep learning can make segmentations less time-consuming and more reliable. We organized the Surgical Planning in PedIatric Neuroblastoma (SPPIN) challenge, to stimulate developments and benchmarking of automatic segmentation of neuroblastoma on MRI. SPPIN is the first segmentation challenge in extracranial pediatric oncology. Nine teams provided a valid submission. Evaluation was based on the Dice similarity coefficient (Dice score), the 95th percentile of the Hausdorff distance (HD95), and the volumetric similarity (VS). A combination of these scores determined the ranking of the teams. The spread in the median evaluation scores per team was large (Dice: 0.21–0.82; HD95: 63.31–7.69; VS: 0.31–0.91). The top-performing team achieved a median Dice score of 0.82 (with an HD95 of 7.69 mm and a VS of 0.91) using a large, pre-trained model. However, in the pre-operative segmentations, significantly lower evaluation scores were observed. Our results indicate that pre-training might be useful in small, pediatric datasets. Although the general results of the winning team were high, they were insufficient to use for surgical planning in small, pre-operative tumors.